Madison Asset Management LLC reduced its stake in Medtronic PLC (NYSE:MDT) by 35.4% in the third quarter, selling over 93,000 shares but still retaining roughly 170,000 shares valued at $16.2 million. The medical technology company has experienced positive momentum due to its acquisition of CathWorks and analyst upgrades, though an antitrust verdict of $381.7 million could impact its near-term earnings and valuation. Medtronic recently reported strong earnings, exceeding analyst expectations, and announced a quarterly dividend.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Medtronic PLC $MDT Shares Sold by Madison Asset Management LLC
Madison Asset Management LLC reduced its stake in Medtronic PLC (NYSE:MDT) by 35.4% in the third quarter, selling over 93,000 shares but still retaining roughly 170,000 shares valued at $16.2 million. The medical technology company has experienced positive momentum due to its acquisition of CathWorks and analyst upgrades, though an antitrust verdict of $381.7 million could impact its near-term earnings and valuation. Medtronic recently reported strong earnings, exceeding analyst expectations, and announced a quarterly dividend.